Giant cell tumour of tendon sheath – Life with Disease

Go back

Giant cell tumour of tendon sheath is a slow-growing, noncancerous growth that develops in the soft tissue surrounding joints and tendons, most commonly affecting the fingers and hands. While these tumours are always benign and never become cancerous, they can still cause discomfort, limit movement, and sometimes return after treatment.

Understanding the Outlook for Giant Cell Tumour of Tendon Sheath

When someone receives a diagnosis of giant cell tumour of tendon sheath, one of the first questions that comes to mind is naturally about what the future holds. The good news is that this condition, while requiring medical attention, has a generally positive outlook when properly treated. These tumours are benign, which means they are not cancer and will never turn into cancer. This is an important distinction that can provide significant relief to patients and their families[1].

The prognosis for people with localized giant cell tumour of tendon sheath—the most common type affecting the hands and feet—is typically excellent. After surgical removal, many patients experience complete resolution of their symptoms and can return to their normal activities. However, the journey isn’t always completely straightforward. One of the main concerns with this condition is the possibility of the tumour returning after it has been removed. Studies have shown that recurrence rates vary, with some research indicating that between 5 to 45 percent of patients may experience a return of the growth, depending on various factors[2][4].

Several factors influence whether a tumour might come back. The location of the growth plays a significant role—tumours near the small joints at the tips of the fingers, known as the distal interphalangeal joints, tend to have higher recurrence rates. The presence of bone changes visible on X-rays, where the tumour has pressed against the bone creating an indentation, is another warning sign that the tumour might be more challenging to eliminate completely. Additionally, if the original tumour had multiple small satellite nodules around the main mass, these can be missed during surgery and grow back over time[4].

The surgical technique used for removal matters tremendously. When surgeons use magnifying loupes or operating microscopes during the procedure, they can identify and remove even tiny extensions of the tumour that might otherwise be left behind. This meticulous approach has been shown to reduce recurrence rates significantly. Some experienced surgeons report recurrence rates as low as approximately 7 percent when using magnification and performing careful, complete removal of all tumour tissue[4].

⚠️ Important
People who have had a giant cell tumour of tendon sheath removed are at increased risk of developing arthritis in the affected joint later in life. Both rheumatoid arthritis and osteoarthritis occur more frequently in joints that have been affected by these tumours. Regular follow-up with your healthcare provider can help catch and manage these changes early[1].

For the less common diffuse type of giant cell tumour of tendon sheath, the outlook requires more careful consideration. These tumours grow more aggressively, spread more widely through the tissue, and affect the joint both from inside and outside. They are much more likely to return after surgery, with multiple recurrences being common. The diffuse form typically affects larger joints like the knee, ankle, or hip, and often requires a more comprehensive treatment approach. In recent years, medication options have become available for patients with diffuse disease that cannot be safely removed with surgery, offering hope for better long-term control[3][8].

Long-term survival is not typically a concern with giant cell tumour of tendon sheath because the condition does not shorten life expectancy. Unlike cancerous tumours, these growths do not spread to distant parts of the body. The main impact is on quality of life through pain, stiffness, and reduced function of the affected area. With appropriate treatment and follow-up, most people can expect to maintain good function and manage any symptoms effectively.

How the Disease Develops Without Treatment

Understanding what happens if giant cell tumour of tendon sheath is left untreated helps explain why seeking medical care is important. These tumours are characterized by being slow-growing, which means many people live with a lump or bump for months or even years before seeking medical attention. During this time, the growth gradually increases in size, though the rate varies considerably from person to person[3].

In the early stages, a person might notice a small, firm lump near a joint or along a finger. Initially, this lump may cause no pain or discomfort and might be dismissed as insignificant. The tumour appears as a discrete, firm mass that doesn’t move much when pressed because it’s attached to the underlying tendon sheath or joint lining. As weeks and months pass, the lump slowly becomes larger and more noticeable.

As the tumour grows, it begins to exert pressure on surrounding structures. The tendons that control finger or hand movement may become compressed, leading to subtle changes in how that digit functions. People might notice they can’t make a full fist, or that picking up small objects becomes slightly awkward. The pressure on nearby nerves can create numbness or tingling in the affected finger or area beyond the tumour. This nerve compression might come and go initially but tends to become more persistent as the tumour enlarges[1][3].

One of the natural progressions that causes people to finally seek treatment is the development of pain. While giant cell tumours of tendon sheath are often painless in their early stages, as they grow larger, they create discomfort. The pain typically worsens with movement of the affected joint or when pressure is applied to the area. Activities that require gripping or fine motor control may become uncomfortable or difficult to perform.

The joint nearest to the tumour begins to show signs of being affected. Stiffness develops, making it harder to bend or straighten the finger or move the joint through its full range of motion. A catching, popping, or locking sensation might occur when trying to move the joint. The joint may feel unstable or weak, as if it might give way during use. Swelling around the joint becomes noticeable, and the skin over the area may feel warm to the touch[1].

In more advanced cases where the tumour has been present for a very long time, it can begin to affect the bone. The constant pressure from the growing mass creates an indentation or erosion in the bone adjacent to the tumour. These bone changes are visible on X-rays and indicate that the tumour has been present for an extended period. In rare instances, the weakening of the bone from this pressure can make fractures more likely[2][4].

The diffuse type of giant cell tumour of tendon sheath, if left untreated, follows a more concerning path. Because it grows more rapidly and spreads more extensively through the joint tissues, it causes more severe damage over time. The cartilage that cushions the joint gradually breaks down, and the bones that form the joint can become damaged. This destruction leads to degenerative changes similar to arthritis, with chronic pain, significant stiffness, and progressive loss of joint function. The joint may become deformed, and the ability to use the affected limb for daily activities becomes increasingly compromised[3][10].

Potential Complications and Unfavorable Developments

While giant cell tumour of tendon sheath is a benign condition, several complications can arise that make the situation more challenging for patients. Understanding these potential problems helps patients and their families prepare for and recognize warning signs that require medical attention.

The most common complication is recurrence of the tumour after surgical removal. This happens when small clusters of tumour cells or tiny satellite nodules are inadvertently left behind during the initial surgery. These remaining cells can gradually grow back, forming a new tumour in the same location. Recurrence can occur months or even years after the original surgery, which is why long-term follow-up is recommended. When a tumour returns, it often requires another surgical procedure, and each subsequent surgery may be more technically challenging because of scar tissue from previous operations[4][10].

Joint damage represents another significant complication, particularly when the tumour has been present for a long time or when the diffuse type is involved. The tumour can invade and damage the cartilage that covers the ends of bones in the joint. Once cartilage is damaged, it does not regenerate, leading to permanent changes in how the joint functions. The protective synovial lining that produces lubricating fluid for the joint can also be destroyed by the tumour. These changes set the stage for early development of arthritis, even in younger patients who would not typically be at risk for this condition[1][3].

Nerve damage is a complication that can occur both from the tumour itself and from surgical treatment. As the tumour grows, it may compress or stretch nearby nerves, leading to numbness, tingling, or altered sensation in the affected area. In the fingers, this might mean loss of normal sensation at the fingertip. During surgery to remove the tumour, nerves running near the operative site are at risk of being injured, even with the most careful surgical technique. While temporary numbness after surgery is common and usually resolves, permanent nerve damage occasionally occurs, resulting in persistent areas of numbness or abnormal sensation[2].

Tendon and ligament injury can complicate both the disease itself and its treatment. The tumour grows within or around the tendon sheath, and in some cases, it may invade the tendon itself. This invasion can weaken the tendon, potentially leading to rupture if significant force is applied. During surgical removal, the surgeon must sometimes remove portions of damaged tendon or cut through supporting ligaments to access and remove the entire tumour. When this happens, the joint may become less stable, or the normal mechanics of how tendons move may be altered, affecting function[8].

Bone erosion and fracture risk increase in cases where the tumour has caused pressure indentations in nearby bone. These areas of thinned bone are structurally weaker than normal bone. While actual fractures are uncommon, they can occur, particularly if the affected bone is subjected to unusual stress or trauma. The presence of bone erosion visible on imaging studies is also associated with higher recurrence rates and more difficult surgical removal[1][4].

For patients with the diffuse type, local aggressive behavior presents unique challenges. Unlike the localized form, diffuse giant cell tumour of tendon sheath can infiltrate widely through tissues, making complete surgical removal very difficult or impossible without causing unacceptable damage to surrounding structures. The tumour may wrap around blood vessels, nerves, and tendons in a way that makes dissecting it away extremely challenging. This aggressive local spread leads to high recurrence rates, with some patients experiencing multiple recurrences despite repeated surgical interventions[3][10].

Chronic pain and disability can develop as a long-term complication. Even after successful tumour removal, some patients continue to experience pain in the affected area. This pain may result from joint damage, nerve injury, or changes in how tissues have healed after surgery. Stiffness and reduced range of motion may persist, affecting the person’s ability to perform daily activities or work tasks. Hand function is particularly important for most occupations and daily living activities, so complications affecting the fingers or hand can have significant impacts on quality of life.

⚠️ Important
Although giant cell tumour of tendon sheath is classified as benign, in extremely rare cases, it can transform into a malignant (cancerous) tumour. This transformation is exceptionally uncommon, but it highlights why proper diagnosis, complete removal, and regular follow-up are important. Any rapid growth of a new or recurrent lump should be reported to your doctor immediately[12].

Surgical complications, while uncommon, can include infection, excessive bleeding, poor wound healing, or excessive scar tissue formation. These issues may require additional treatment or procedures to resolve. In the hand, excessive scar tissue can create adhesions that restrict tendon movement, leading to stiffness and reduced function.

Impact on Daily Living and Quality of Life

Living with giant cell tumour of tendon sheath affects people in multiple dimensions of their daily lives. The physical symptoms are often the most obvious, but the emotional, social, and practical impacts can be equally significant and deserve careful consideration.

From a physical standpoint, the location of these tumours plays a crucial role in how much they interfere with everyday activities. Because they most commonly affect the fingers, thumb, and hand, activities that most people take for granted can become challenging. Writing with a pen, typing on a keyboard, buttoning shirts, tying shoelaces, or opening jars may become difficult or painful. For people whose tumours affect the thumb—one of the most common locations—the loss of normal thumb function can be particularly limiting since the thumb is essential for gripping and manipulating objects[4].

Work life may be significantly affected depending on the person’s occupation. Jobs requiring fine motor skills, such as those performed by surgeons, dentists, musicians, artists, or craftspeople, can become challenging or impossible to perform at the usual level. Manual laborers who need to grip tools firmly or repeatedly use their hands may experience pain and fatigue that limits their work capacity. Even office workers who type extensively may need to request accommodations or modified duties. The financial implications of reduced work capacity or time off for medical appointments and surgery can create stress and worry.

Participation in hobbies and recreational activities often suffers. People who enjoy activities like playing musical instruments, painting, knitting, gardening, or playing sports that require hand use may need to reduce or stop these activities temporarily or permanently. This loss of enjoyable pastimes can contribute to feelings of frustration and diminished quality of life. Physical exercise routines may need to be modified to avoid movements that aggravate the affected joint.

The emotional impact of living with this condition should not be underestimated. Anxiety about what the lump might be often precedes diagnosis, with many people worrying about cancer until they receive reassurance that the growth is benign. Even after diagnosis, concerns about surgery, potential complications, and the possibility of recurrence can create ongoing worry. Some patients report feeling anxious about whether every new bump or sensation represents another tumour.

Body image concerns sometimes arise, particularly when the tumour is large or located in a visible area. The hand is always on display in social and professional situations, and a noticeable lump can make people feel self-conscious. After surgery, scars on the hand or fingers may be visible and serve as reminders of the condition. For some individuals, particularly younger people or those in professions where appearance matters, these cosmetic concerns can be distressing.

Sleep may be disrupted by pain or discomfort from the tumour or after surgery. Finding comfortable sleeping positions that don’t put pressure on the affected area can be challenging, and pain may wake people during the night. Adequate rest is important for healing and overall wellbeing, so sleep disturbances can have cascading effects on energy levels, mood, and ability to cope.

Social interactions and relationships can be affected in subtle ways. Simple social gestures like shaking hands may be uncomfortable or painful. People might avoid social situations where they feel their hand will be noticed or where they cannot easily explain their condition. Family members may need to take over tasks that the affected person can no longer perform easily, which can create feelings of dependence or guilt.

Managing daily self-care activities becomes more challenging. Tasks like washing and styling hair, applying makeup, shaving, or cutting fingernails may require assistance or adaptive techniques. In the bathroom, manipulating small items like toothbrushes or floss can be awkward with limited hand function. Getting dressed requires more time and effort, particularly with items like jewelry, buttons, or zippers.

Parents with young children face unique challenges. Lifting and carrying a baby, changing diapers, preparing bottles, or helping older children with their needs all require full hand function. The inability to perform these essential parenting tasks comfortably can be emotionally distressing and may require asking for more help from partners or other family members.

After surgical treatment, the recovery period brings its own set of challenges. The affected hand or finger may need to be immobilized in a splint or dressing for a period of time, making the person temporarily even more limited than before surgery. Pain medications may cause drowsiness or other side effects that interfere with daily activities. Physical or occupational therapy may be needed to regain full function, requiring additional time commitments and effort.

There are strategies that can help people cope with these limitations. Occupational therapists can provide valuable assistance by teaching energy conservation techniques, suggesting adaptive equipment, and showing exercises to maintain function. Adaptive devices such as built-up handles on utensils, button hooks, or special tools can make daily tasks easier. Learning to use the non-dominant hand for some activities can help maintain independence. Pacing activities and taking regular breaks can prevent overuse pain and fatigue.

Maintaining a positive attitude while acknowledging legitimate frustrations is important for emotional wellbeing. Support from family and friends who understand the limitations without being overprotective can help maintain independence and self-esteem. Some people find connecting with others who have had similar experiences, whether through online communities or local support groups, provides valuable emotional support and practical advice[14].

Supporting Your Loved One Through Clinical Trials

When a family member receives a diagnosis of giant cell tumour of tendon sheath, particularly the diffuse type that may be difficult to treat with surgery alone, families may hear about clinical trials as a treatment option. Understanding what clinical trials are and how to support a loved one considering participation can help families navigate this aspect of care more confidently.

Clinical trials are research studies that test new treatments, medications, or procedures to determine if they are safe and effective. For giant cell tumour of tendon sheath, clinical trials have been crucial in developing the newer medication options that are now available. These studies typically involve giving some patients the new treatment being tested while comparing the results to either a placebo (inactive substance) or the current standard treatment. Researchers carefully monitor participants to measure how well the treatment works and what side effects occur[8][10].

Families should understand that participation in clinical trials is always voluntary. No one can force a patient to join a study, and patients can withdraw from a trial at any time without it affecting their regular medical care. The decision to participate should be made carefully after receiving complete information about the study’s purpose, procedures, potential benefits, and possible risks. Healthcare providers are required to provide this information in a process called informed consent.

For patients with diffuse giant cell tumour of tendon sheath that cannot be safely removed with surgery or that keeps returning after multiple surgeries, clinical trials may offer access to promising new treatments before they become widely available. Several medications targeting the specific biological mechanisms that cause these tumours to grow have been studied in clinical trials. Some of these treatments have shown the ability to shrink tumours, reduce symptoms like pain and swelling, and improve joint function[8][10].

Family members can play an important supportive role when a loved one is considering a clinical trial. Start by helping gather information. Research the specific trial being considered, understand what it involves, and prepare questions to ask the research team. Important questions include: What is the purpose of this study? What treatments will be involved? How long will participation last? What are the potential benefits and risks? Will there be any costs? What monitoring and follow-up will be required? Are there travel requirements? What happens after the trial ends?

Attend appointments with your loved one when possible. Having another person present during discussions with the research team can be helpful because they may hear or remember information differently. Two sets of ears are better than one when processing complex medical information. Take notes during these meetings or ask if you can record the conversation for later review. Don’t hesitate to ask the healthcare team to explain anything that’s unclear.

Help evaluate whether the practical demands of the trial are manageable. Some studies require frequent visits to the treatment center, which may involve travel, time away from work, and associated costs. Consider how these requirements will fit into family schedules and whether the logistics are realistic. Discuss with the research team what support services might be available to help with transportation or other practical needs.

Provide emotional support throughout the decision-making process. Your family member may feel anxious about the unknown aspects of an experimental treatment or guilty about the impact their participation might have on family life. Listen without judgment to their concerns and fears. Remind them that whatever decision they make will be supported by the family. Acknowledge that clinical trials offer both opportunities and uncertainties.

If your loved one decides to participate, help keep track of the treatment schedule, appointments, and any symptoms or side effects that need to be reported. Create a system for managing medications if the trial involves taking pills at specific times. Some families find it helpful to keep a journal documenting the treatment journey, including how the person feels, any changes in symptoms, and questions that arise between appointments.

Be prepared for potential side effects, which vary depending on the specific treatment being studied. Newer medications for diffuse giant cell tumour of tendon sheath can cause side effects that affect the liver, change hair or skin color, cause fatigue, or create other symptoms. Understanding what side effects might occur and when to contact the medical team is important for safety[8].

Help maintain perspective about the dual nature of clinical trial participation. On one hand, the patient receives close medical monitoring and access to potentially beneficial new treatments. On the other hand, there are no guarantees the treatment will work, and there may be unexpected side effects. The patient is also contributing to medical knowledge that may help future patients, which many people find meaningful.

Stay in close communication with the research team. If you notice changes in your loved one’s condition or have concerns about side effects, don’t wait for the next scheduled appointment to raise these issues. Clinical trial staff expect and welcome questions and concerns throughout the study period. They need to know about any problems so they can ensure participant safety.

Recognize that participation in a clinical trial can be emotionally and physically demanding for everyone in the family. Make sure to take care of your own wellbeing so you can continue to provide support. Reach out to other family members or friends for help when needed. Some treatment centers offer support services for families of patients in clinical trials.

Finding appropriate clinical trials requires some research. The patient’s healthcare provider is usually the best starting point and may be aware of relevant studies. Online resources like clinicaltrials.gov provide searchable databases of studies currently recruiting participants. Patient advocacy organizations focused on rare tumours sometimes maintain lists of relevant clinical trials and can provide guidance on the enrollment process.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Pexidartinib (Turalio) – A CSF1R inhibitor approved by the FDA in 2019 for tenosynovial giant cell tumor (TGCT). It works by blocking the production of inflammatory mediators that promote tumor cell growth. Used for symptomatic, advanced disease that cannot be improved with surgery.
  • Vimseltinib (Romvimza) – A CSF1R inhibitor approved by the FDA in February 2025 for treatment of symptomatic TGCT in adult patients for whom surgical resection would cause worsening functional limitation or severe morbidity.
  • Imatinib – A medication mentioned as being evaluated in clinical studies for its effectiveness against TGCT.

Ongoing Clinical Trials on Giant cell tumour of tendon sheath

  • Study of emactuzumab compared to placebo in patients with tenosynovial giant cell tumor

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium France Italy The Netherlands Poland +2
  • Study on the Safety and Effectiveness of ABSK021 for Patients with Tenosynovial Giant Cell Tumor

    Not recruiting

    1 1
    Investigated diseases:
    France Italy The Netherlands Poland Spain

References

https://my.clevelandclinic.org/health/diseases/24276-tenosynovial-giant-cell-tumor

https://www.orthobullets.com/hand/6092/giant-cell-tumor-of-tendon-sheath

https://emedicine.medscape.com/article/1253223-overview

https://pmc.ncbi.nlm.nih.gov/articles/PMC3122708/

https://journalmsr.com/giant-cell-tumor-of-the-tendon-sheath-a-critical-review-of-current-diagnostic-and-therapeutic-approaches-with-treatment-recommendations-for-hand-and-foot-lesions/

https://www.upmc.com/services/orthopaedics/conditions/giant-cell-tumor

https://my.clevelandclinic.org/health/diseases/24276-tenosynovial-giant-cell-tumor

https://emedicine.medscape.com/article/1253223-treatment

https://www.orthobullets.com/hand/6092/giant-cell-tumor-of-tendon-sheath

https://pmc.ncbi.nlm.nih.gov/articles/PMC7643913/

https://journalmsr.com/giant-cell-tumor-of-the-tendon-sheath-a-critical-review-of-current-diagnostic-and-therapeutic-approaches-with-treatment-recommendations-for-hand-and-foot-lesions/

https://www.nationwidechildrens.org/conditions/tenosynovial-giant-cell-tumors

https://www.upmc.com/services/orthopaedics/conditions/giant-cell-tumor

https://www.everydayhealth.com/rare-diseases/lifestyle-habits-that-may-help-you-manage-tenosynovial-giant-cell-tumors/

FAQ

Is giant cell tumour of tendon sheath a cancer?

No, giant cell tumour of tendon sheath is always benign, meaning it is not cancer and cannot become cancer. It is a noncancerous growth that forms in the soft tissue around joints and tendons. While it can cause symptoms and may return after treatment, it does not spread to other parts of the body like cancer does.

Why do these tumours come back after surgery?

Recurrence happens when tiny clusters of tumour cells or small satellite nodules are left behind during the initial surgery. These remaining cells gradually grow back over time. Using magnification during surgery, complete removal of all visible tumour tissue including satellite nodules, and careful surgical technique can significantly reduce the risk of recurrence.

What causes giant cell tumour of tendon sheath to develop?

The exact cause is not fully understood, but research suggests it may be related to changes in chromosomes, specifically a process called translocation where chromosomes break apart and reconnect incorrectly. Various theories have included trauma, inflammation, and metabolic factors, but no single cause has been definitively proven.

How long does recovery take after surgery to remove this tumour?

Recovery time varies depending on the size and location of the tumour and the extent of surgery required. The affected area may need to be immobilized in a splint for a period of time after surgery. Many patients require physical or occupational therapy to regain full function. Complete recovery can take several weeks to months.

Are there treatment options besides surgery?

For the localized type affecting fingers and hands, surgery is the main treatment. However, for diffuse giant cell tumour of tendon sheath that cannot be safely removed with surgery or keeps returning, medication options are now available. The FDA has approved pexidartinib and vimseltinib, which are drugs that work by blocking specific biological pathways that cause the tumour to grow.

🎯 Key Takeaways

  • Giant cell tumour of tendon sheath is always benign and never becomes cancerous, though it can still cause significant symptoms and limitations.
  • The thumb and fingers are the most common locations, making even small tumours potentially quite disabling for daily activities.
  • Recurrence rates after surgical removal vary widely from 5 to 45 percent depending on surgical technique, tumour location, and other factors.
  • Using magnification during surgery significantly improves complete tumour removal and reduces the chance it will return.
  • People who’ve had this tumour are at higher risk for developing arthritis in the affected joint later in life.
  • The diffuse type is more aggressive than the localized type and requires more complex treatment approaches.
  • Two medications, pexidartinib and vimseltinib, are now FDA-approved specifically for difficult-to-treat cases of this condition.
  • These tumours were incorrectly called “cancers” when first described in 1852, causing unnecessary fear for over a century until their true benign nature was understood.